Quick Answer
EXAGEN INC. reported Long Term Debt of $22.26 million for the year ending 2025.
- EXAGEN INC. showed an increase of +12.3% in Long Term Debt from 2024 to 2025.
- This data is from EXAGEN INC.'s annual report (Form 10-K), filed with the SEC on March 10, 2026.
- XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2019: $25.68 million | Q1 2020: $26.05 million | Q2 2020: $26.25 million | Q3 2020: $26.45 million | Q1 2021: $26.86 million | Q2 2021: $27.07 million | Q3 2021: $27.29 million | Q1 2022: $27.65 million | Q2 2022: $27.83 million | Q3 2022: $28.01 million | Q1 2023: $29.09 million | Q2 2023: $19.15 million | Q3 2023: $19.19 million | Q1 2024: $19.27 million | Q2 2024: $19.83 million | Q3 2024: $19.82 million | Q1 2025: $18.41 million | Q2 2025: $22.31 million | Q3 2025: $22.26 million.
- Over the full 8 years of available data (2018 to 2025), EXAGEN INC.'s Long Term Debt has declined by 9.6%.
- Historical annual values: Fiscal year 2025: $22.26 million | Fiscal year 2024: $19.82 million | Fiscal year 2023: $19.23 million | Fiscal year 2022: $28.78 million | Fiscal year 2021: $27.48 million | Fiscal year 2020: $26.66 million | Fiscal year 2019: $25.85 million | Fiscal year 2018: $24.62 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: